As of Nov 17
| 0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for aTyr Pharma Inc have a median target of 4.00, with a high estimate of 7.00 and a low estimate of 4.00. The median estimate represents a +3.90% increase from the last price of 3.85.
The current consensus among 5 polled investment analysts is to Hold stock in aTyr Pharma Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.